🇺🇸 FDA
Patent

US 12171803

Methods of CD40 and toll like receptor immune activation

granted A61KA61K35/76A61K38/177

Quick answer

US patent 12171803 (Methods of CD40 and toll like receptor immune activation) held by The Board of Regents of the University of Texas System expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/76, A61K38/177, A61K38/191, A61K45/06